{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:52:20Z","timestamp":1790013140674,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.euroneuro.2008.04.014","type":"journal-article","created":{"date-parts":[[2008,6,7]],"date-time":"2008-06-07T09:13:27Z","timestamp":1212830007000},"page":"667-672","source":"Crossref","is-referenced-by-count":36,"title":["Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia"],"prefix":"10.1016","volume":"18","author":[{"given":"Bur\u00e7 \u00c7.","family":"Poyraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cana","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"Balc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2008.04.014_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4000815","article-title":"Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia","volume":"6","author":"Boin","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4158\/EP.5.5.239","article-title":"Effects of carbamazepine on the hypothalamic-pituitary-thyroid axis","volume":"5","author":"Bongu","year":"1999","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/jaut.1995.0033","article-title":"Autoantibody profile in the sera of women with hyperprolactinemia","volume":"8","author":"Buskila","year":"1995","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-3223(90)90467-G","article-title":"Neuroleptic-associated autoantibodies","volume":"27","author":"Canoso","year":"1990","journal-title":"A prevalence study. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib5","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1528-1167.2006.00821.x","article-title":"The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate","volume":"47","author":"Cansu","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib6","first-page":"143","article-title":"Antipsychotic-induced hyperprolactinemia and sexual dysfunction","volume":"36","author":"Compton","year":"2002","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib10","first-page":"81","article-title":"Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"11","author":"El-Sherif","year":"2004","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib11","first-page":"147","article-title":"An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs","volume":"90","author":"Giusti","year":"1999","journal-title":"Recenti Prog. Med."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s10067-007-0638-6","article-title":"Thyroid disease in Sj\u00f6gren's syndrome","volume":"26","author":"Jara","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arcmed.2004.11.007","article-title":"Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies","volume":"36","author":"Kramer","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(01)01217-3","article-title":"High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure","volume":"51","author":"Kupka","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00002512-200522010-00002","article-title":"Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment","volume":"22","author":"Laurberg","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5728(00)00302-7","article-title":"Prolactin in autoimmunity and antitumor defence","volume":"109","author":"Matera","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2007.02.046","article-title":"Risk factors for development of subclinical hypothyroidism during valproic acid therapy","volume":"151","author":"Mikati","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pediatrneurol.2005.08.032","article-title":"Central hypothyroidism with oxcarbazepine therapy","volume":"34","author":"Miller","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib19","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/archinte.148.10.2278","article-title":"Marked hyperprolactinemia in subclinical hypothyroidism","volume":"148","author":"Olive","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/00048679409080785","article-title":"High prevalence of thyroid function test abnormalities in chronic schizophrenia","volume":"28","author":"Othman","year":"1994","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/PR0.10.3.799-812","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3956(00)00032-7","article-title":"Effects of antipsychotic drugs on cytokine networks","volume":"34","author":"Pollm\u00e4cher","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beem.2004.11.003","article-title":"Thyroid peroxidase autoantibodies in euthyroid subjects","volume":"19","author":"Prummel","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/eje.0.1500605","article-title":"The environment and autoimmune thyroid diseases","volume":"150","author":"Prummel","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2265.2003.01694.x","article-title":"Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization","volume":"58","author":"Raber","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/brbi.2001.0648","article-title":"Review of immunological and immunopathological findings in schizophrenia","volume":"15","author":"Rothermundt","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.iac.2004.01.009","article-title":"Chronic urticaria and thyroid disease","volume":"24","author":"Rumbyrt","year":"2004","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s004060050051","article-title":"Autoantibodies against 60-kDa heat shock protein in schizophrenia","volume":"248","author":"Schwarz","year":"1998","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.pnpbp.2007.06.002","article-title":"Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia","volume":"31","author":"Semiz","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.04.014_bib30","unstructured":"Soykan, C., 1989. Institutional differences and case typicality as related to diagnosis system severity, prognosis and treatment. Unpublished Master's thesis, Middle East University, Ankara, Turkey."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0447.1995.tb09581.x","article-title":"Antinuclear autoantibodies in chronic schizophrenia","volume":"92","author":"Spivak","year":"1995","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","article-title":"Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited","volume":"27","author":"Strous","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib33","first-page":"881","article-title":"Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients","volume":"28","author":"Svestka","year":"2005","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0376-8716(02)00362-9","article-title":"Smoking and substance abuse in outpatients with schizophrenia: a 2-year follow-up study in Turkey","volume":"70","author":"Uzun","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1568-9972(02)00081-2","article-title":"Prolactin and autoimmunity","volume":"1","author":"Vera-Lastra","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00024677-200302010-00003","article-title":"Hyperprolactinemia: pathophysiology and management","volume":"2","author":"Verhelst","year":"2003","journal-title":"Treat. Endocrinol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.4049\/jimmunol.176.2.848","article-title":"Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3","volume":"176","author":"Watanabe","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bmj.324.7332.250","article-title":"Hyperprolactinaemia caused by antipsychotic drugs","volume":"324","author":"Wieck","year":"2002","journal-title":"BMJ."},{"key":"10.1016\/j.euroneuro.2008.04.014_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2006.08.004","article-title":"5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes","volume":"181","author":"Yin","year":"2006","journal-title":"J. Neuroimmunol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X08001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X08001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T00:58:06Z","timestamp":1545958686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X08001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0924977X08001120"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2008.04.014","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}